Correction: Characterization of chitosan- and β-cyclodextrin-modified forms of magnesium-doped hydroxyapatites as enhanced carriers for levofloxacin: loading, release, and anti-inflammatory properties

May N. Bin Jumah; Sarah I. Al Othman; Awatif Abdulaziz Alomari; Ahmed A. Allam; Mostafa R. Abukhadra

doi:10.1039/D4RA90068E

You do not have JavaScript enabled. Please enable JavaScript to access the full features of the site or access our non-JavaScript page.

Correction: Characterization of chitosan- and β-cyclodextrin-modified forms of magnesium-doped hydroxyapatites as enhanced carriers for levofloxacin: loading, release, and anti-inflammatory properties

May N. Bin Jumah,^a Sarah I. Al Othman,^a Awatif Abdulaziz Alomari,^a Ahmed A. Allam^bc and Mostafa R. Abukhadra*^de

Author affiliations

* Corresponding authors

^a Biology Department, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia

^b Zoology Department, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt

^c Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Kingdom of Saudi Arabia

^d Geology Department, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt
E-mail: Abukhadra89@Science.bsu.edu.eg
Tel: +2001288447189

^e Materials Technologies and Their Applications Lab, Geology Department, Faculty of Science, Beni-Suef University, Beni-Suef City, Egypt

Abstract

Correction for ‘Characterization of chitosan- and β-cyclodextrin-modified forms of magnesium-doped hydroxyapatites as enhanced carriers for levofloxacin: loading, release, and anti-inflammatory properties' by May N. Bin Jumah et al., RSC Adv., 2024, 14, 16991–17007, https://doi.org/10.1039/d4ra02144d.

Download options Please wait...

Associated articles

Characterization of chitosan- and β-cyclodextrin-modified forms of magnesium-dop…

Article information

DOI: https://doi.org/10.1039/D4RA90068E
Article type: Correction
Submitted: 31 May 2024
Accepted: 31 May 2024
First published: 06 Jun 2024
This article is Open Access

Download Citation

RSC Adv., 2024,14, 18181-18181

Permissions

Request permissions

Correction: Characterization of chitosan- and β-cyclodextrin-modified forms of magnesium-doped hydroxyapatites as enhanced carriers for levofloxacin: loading, release, and anti-inflammatory properties

M. N. Bin Jumah, S. I. Al Othman, A. A. Alomari, A. A. Allam and M. R. Abukhadra, RSC Adv., 2024, 14, 18181 DOI: 10.1039/D4RA90068E

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Social activity

Fetching data from CrossRef.
This may take some time to load.

RSC Advances

Correction: Characterization of chitosan- and β-cyclodextrin-modified forms of magnesium-doped hydroxyapatites as enhanced carriers for levofloxacin: loading, release, and anti-inflammatory properties

Abstract

Associated articles

Article information

Download Citation

Permissions

Correction: Characterization of chitosan- and β-cyclodextrin-modified forms of magnesium-doped hydroxyapatites as enhanced carriers for levofloxacin: loading, release, and anti-inflammatory properties

Social activity

Search articles by author

Spotlight

Advertisements